CytomX Therapeutics (CTMX) Reports revenue

CytomX Therapeutics (NASDAQ: CTMX) reportedrevenue for the quarter came in at $26.6 million versus the consensus estimate of $19.6 million.

For earnings history and earnings-related data on CytomX Therapeutics (CTMX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AXT appoints Tracy Liu to its board of directors
• Pfizer lung cancer drug misses survival goal in Phase 3 trial